1.Addressing challenges in the clinical applications associated with CRISPR/Cas9 technology and ethical questions to prevent its misuse.
Xiang Jin KANG ; Chiong Isabella Noelle CAPARAS ; Boon Seng SOH ; Yong FAN
Protein & Cell 2017;8(11):791-795
Animals
;
CRISPR-Cas Systems
;
Cystic Fibrosis
;
genetics
;
therapy
;
Gene Editing
;
ethics
;
Genetic Therapy
;
ethics
;
methods
;
Humans
;
Mice
;
Neoplasms
;
genetics
;
therapy

Result Analysis
Print
Save
E-mail